IL28B polymorphism,Explanation for Different Responses to Therapy in Hepatitis C Patients

authors:

avatar Heidar Sharafi 1 , avatar Seyed Moayed Alavian ORCID 2 , *

Armin Pathobiology Laboratory, IR Iran
Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, alavian@thc.ir, IR Iran
Hepatitis Monthly: Vol.11, issue 12; 958-959
article type: Editorial
received: December 6, 2011
accepted: December 30, 2011
DOI: https://doi.org/10.5812/kowsar.1735143X.794

how to cite: Sharafi H, Alavian S. IL28B polymorphism,Explanation for Different Responses to Therapy in Hepatitis C Patients. Hepat Mon. 2011;11(12): 958-959. https://doi.org/10.5812/kowsar.1735143X.794.

Abstract

Implication for health policy/practice/research/medical education:
This article focuses on impact of IL28B polymorphisms on hepatitis C outcomes. This study is recommended to clinicians and researchers in the field of viral hepatitis.

Please cite this paper as:
Sharafi H, Alavian SM. IL28B polymorphism, explanation for Different Responses to Therapy in Hepatitis C patients. Hepat
Mon. 2011; 11(12):958-9. DoI: 10.5812/kowsar.1735143X.794

Full Text

Full text is available in PDF